# South Korea Vascular Embolization Market > South Korea Vascular Embolization Market Research Report: Size, Share, Trend Analysis By Embolization Technique (Coiling Devices, Non-coiling Devices) and By Applications (Peripheral Vascular Disease, Oncology, Neurology, Urology, Other) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 9.89% - **2024:** $ 52.2 Million - **2025:** $ 57.37 Million - **2035:** $ 147.25 Million - **Key Players:** Medtronic (US), Boston Scientific (US), Terumo Corporation (JP), Johnson & Johnson (US), Stryker Corporation (US), B. Braun Melsungen AG (DE), Cook Medical (US), Abbott Laboratories (US), AngioDynamics (US) **Report ID:** MRFR/HC/50294-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-vascular-embolization-market-52052 --- ## Market Summary ## **South Korea Vascular Embolization Market Overview** As per MRFR analysis, the South Korea Vascular Embolization Market Size was estimated at 47.54 (USD Million) in 2023. The South Korea Vascular Embolization Market Industry is expected to grow from 52.25(USD Million) in 2024 to 156.75 (USD Million) by 2035. The South Korea Vascular Embolization Market CAGR (growth rate) is expected to be around 10.503% during the forecast period (2025 - 2035). ### **Key South Korea Vascular Embolization Market Trends Highlighted** The South Korean Vascular Embolisation Market is experiencing substantial growth, which is being driven by a number of critical market drivers. The demand for advanced medical procedures is on the rise in South Korea due to the ageing population and age-related health complications. In addition, the demand for effective vascular embolisation procedures is increasing due to the increasing prevalence of chronic diseases, including cancer and cardiovascular disorders. Technological advancements are improving the efficacy and safety of these procedures in medical equipment and imaging techniques, which are attracting both clinicians and patients. The integration of minimally invasive techniques and the development of novel embolisation materials that can enhance outcomes are among the opportunities to be investigated in the South Korea market.  Further opportunities for market participants are presented by the government's dedication to improving healthcare infrastructure and promoting innovative therapies. These opportunities can be effectively leveraged through partnerships with local hospitals and research institutions. In recent years, there has been a rise in patient awareness of the advantages of vascular embolisation, which has resulted in a greater number of individuals seeking these procedures. Additionally, there is an increasing emphasis on the development of specialized training for healthcare professionals to enhance the professional skills necessary for these advanced procedures.  The future of this market is being influenced by the emphasis on patient-centered care and individualized treatment plans, as clinicians strive to offer customized solutions that cater to the unique requirements of each patient.In general, the South Korean Vascular Embolisation Market is undergoing a rapid transformation, which is being driven by technological advancements, demographic changes, and a distinct transition to more efficient healthcare delivery models. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ## **South Korea Vascular Embolization Market Drivers** Increasing Incidence of Chronic Diseases The rising prevalence of chronic diseases such as cancer, arteriovenous malformations, and uterine fibroids significantly drives the South Korea Vascular Embolization Market Industry. According to the Ministry of Health and Welfare of South Korea, chronic diseases accounted for approximately 87.5% of the total disease burden in the country, underlining a substantial healthcare challenge. The Korean Cancer Association reported that the number of new cancer cases was estimated to exceed 240,000 in 2020, showing a consistent annual growth of around 3.1%.This increase in chronic disease cases necessitates innovative treatment solutions, including vascular embolization, indicating a robust growth potential for the market in South Korea. Established medical facilities, such as Samsung Medical Center and Seoul National University Hospital, are increasingly adopting vascular embolization techniques, reinforcing this trend in the healthcare landscape of South Korea. Technological Advancements in Medical Devices Advancements in medical technology are substantially propelling the South Korea Vascular Embolization Market. The 2021 National Institute of Health statistics reported a 15% increase in the adoption of minimally invasive procedures facilitated by enhanced medical devices and techniques. This trend is particularly evident in the development of specialized embolization materials, which have been designed to improve efficacy and patient outcomes.South Korean companies like Medtronic and Boston Scientific are pioneering this innovation, contributing to improved precision in vascular embolization processes. As the demand for effective treatment options rises among healthcare providers and patients alike, the integration of advanced technology will further elevate the market growth prospects. Growing Healthcare Expenditure The growing healthcare expenditure in South Korea is a pivotal factor driving the South Korea Vascular Embolization Market Industry. According to Statistics Korea, the country’s healthcare spending increased by 6.2% in 2021 compared to the previous year, reaching approximately USD 88.9 billion. This uptick in spending reflects a commitment to enhancing healthcare infrastructure and access to advanced medical treatments. The Korean government has placed significant emphasis on improving healthcare services, as evidenced by its 'Healthy Korea 2030' initiative, which aims to promote preventive healthcare and efficient treatment methodologies. As more funds are allocated towards advanced medical procedures, including vascular embolization, the market is expected to grow robustly, owing to the prioritization of cutting-edge medical solutions. ## **South Korea Vascular Embolization Market Segment Insights** ### **Vascular Embolization Market Embolization Technique Insights** The Embolization Technique segment within the South Korea Vascular Embolization Market showcases a dynamic landscape influenced by ongoing advancements and changing healthcare needs. Vascular embolization plays a crucial role in treating various vascular conditions, providing an effective intervention for issues such as tumors and vascular malformations. Among the techniques utilized in this field, two categories stand out: Coiling Devices and Non-coiling Devices. Coiling Devices are essential for treating aneurysms, offering a minimally invasive solution that significantly reduces recovery time for patients. The ability to position these devices precisely within the affected vessels enhances the efficacy of treatments and minimizes complications. On the other hand, Non-coiling Devices include various alternatives such as liquid embolic agents, which have gained traction for their versatility and effectiveness in anatomical variations where traditional coiling might be less beneficial. The market dynamics are driven by increasing awareness of vascular disorders and the demand for less invasive surgical options. Additionally, demographic factors such as an aging population in South Korea contribute to the rise in vascular conditions, thereby elevating the need for reliable embolization techniques. Furthermore, ongoing technological innovations and Research and Development investments in both Coiling and Non-coiling Devices continue to expand treatment capabilities, ensuring better patient outcomes. In urban settings, advanced healthcare infrastructure amplifies access to innovative treatment options, driving the adoption of these Embolization Techniques. Ultimately, the South Korea Vascular Embolization Market is characterized by a strong push towards enhancing procedural efficiency and patient safety through enhanced device functionalities and individualized treatment regimens. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ### **Vascular Embolization Market Application Insights** The Application segment of the South Korea Vascular Embolization Market plays a crucial role in addressing various health challenges within the region. This segment encompasses several areas such as Peripheral Vascular Disease, Oncology, Neurology, Urology, and other applications, each contributing significantly to the market dynamics. Peripheral Vascular Disease is a notable component, as it reflects a growing incidence of circulatory disorders in South Korea, driven by factors like an aging population and lifestyle diseases. The Oncology segment is gaining traction due to the rising number of cancer cases, making embolization a critical treatment option for tumor control and management. Neurology applications stand out for their importance in treating conditions like arteriovenous malformations, which enhances patient outcomes through minimally invasive procedures. Urology is also significant as vascular embolization offers innovative approaches for treating renal tumors and bleeding, reducing patient recovery times and risks. Overall, the segmentation reflects the diverse medical landscape of South Korea, where increased awareness and advancements in medical technology are accelerating market growth, providing new opportunities for effective interventions in healthcare. ## **South Korea Vascular Embolization Market Key Players and Competitive Insights** The South Korea Vascular Embolization Market is characterized by a dynamic environment that reflects the growing demand for advanced medical technologies and procedures aimed at treating various vascular conditions. The market has experienced considerable growth due to increasing awareness of embolization therapies, technological advancements, and a rise in the number of procedures performed. As healthcare providers focus on improving patient outcomes and optimizing treatment options, competitive dynamics are continually reshaping the market landscape. Key players are investing in research and development to introduce innovative products, while also engaging in strategic partnerships and collaborations.  The increasing prevalence of chronic diseases and an aging population in South Korea are further driving the necessity for effective vascular treatments, leading to heightened competition and the emergence of new entrants in the market.AngioDynamics has successfully established a strong presence in the South Korea Vascular Embolization Market by leveraging its reputation for providing high-quality medical devices and solutions. The company is particularly noted for its emphasis on innovation, which is evident in its product offerings that cater to various embolization needs. The strength of AngioDynamics lies in its comprehensive understanding of the local healthcare landscape, enabling it to effectively address the specific requirements of South Korean patients and healthcare professionals.  Additionally, AngioDynamics often relies on gathering feedback directly from clinicians to enhance its product lines and streamline functionalities, positioning itself as a trusted partner among vascular specialists. This focus on customer service and product education contributes significantly to the company's competitive advantage in South Korea.Asahi Intecc has carved out a notable segment of the South Korea Vascular Embolization Market, focusing on advanced catheter technologies and other specialized medical devices. The company is widely recognized for its high-quality guidewires and catheter products specifically designed for minimally invasive procedures. Asahi Intecc's strengths include a strong commitment to research and development, facilitating the continuous introduction of cutting-edge products that resonate with the needs of medical professionals in South Korea.  The company has maintained a solid market presence through strategic collaborations with local healthcare providers, enhancing its distribution capabilities. Recent mergers and acquisitions have also bolstered Asahi Intecc's competitive positioning, allowing the company to expand its product portfolio and enter new market segments. These strategies help reinforce its reputation as a leader in vascular embolization solutions, making it a significant player within the South Korean healthcare landscape. **Key Companies in the South Korea Vascular Embolization Market Include** ## **South Korea Vascular Embolization Market Industry Developments** The South Korea Vascular Embolization Market has witnessed significant recent developments, particularly in the domains of technology and strategic movements. Companies such as AngioDynamics and Johnson and Johnson are focusing on advanced embolization techniques, enhancing the effectiveness of treatment options. In March 2023, Meritor, now acquired by BorgWarner, announced entering into collaborative agreements with Boston Scientific to expand accessibility of vascular embolization devices across various healthcare settings in South Korea.  The market has observed growth in valuation, primarily driven by the increasing prevalence of vascular diseases and the rising demand for minimally invasive procedures. Major players, including Abbott Laboratories and Terumo, have experienced a surge in product demand due to technological advancements and improved healthcare infrastructure. In the past two to three years, significant innovations, such as Hologic's enhanced imaging systems and Guerbet's new contrast agents, have further galvanized market interests. The South Korean government's continued investment in healthcare research and development is expected to bolster the Vascular Embolization sector's growth trajectory, signifying a robust future for both domestic and global players in this market. ## **South Korea Vascular Embolization Market Segmentation Insights** ### **Vascular Embolization Market Embolization Technique****Outlook** ### **Vascular Embolization Market Application****Outlook** ## Market Drivers ### Aging Population The demographic shift towards an aging population in South Korea significantly influences the vascular embolization market. By 2025, it is estimated that over 20% of the population will be aged 65 and older, leading to a higher prevalence of age-related vascular conditions. This demographic trend necessitates advanced medical interventions, including embolization procedures, to manage conditions such as aneurysms and arteriovenous malformations. The increasing number of elderly patients is likely to drive demand for vascular embolization treatments, as healthcare providers seek effective solutions to address complex vascular issues. Additionally, the aging population may prompt healthcare systems to prioritize funding for innovative treatments, further supporting the growth of the vascular embolization market. ### Increasing Healthcare Expenditure The rising healthcare expenditure in South Korea is a pivotal driver for the vascular embolization market. As the government allocates more funds towards healthcare, the availability of advanced medical technologies increases. In 2025, healthcare spending is projected to reach approximately $200 billion, reflecting a growth rate of around 5% annually. This financial commitment enables hospitals and clinics to invest in state-of-the-art embolization devices and training for healthcare professionals. Consequently, the vascular embolization market benefits from enhanced access to innovative treatments, which may lead to improved patient outcomes and increased adoption of these procedures. Furthermore, the emphasis on quality healthcare services aligns with the growing demand for minimally invasive procedures, thereby propelling the vascular embolization market forward. ### Supportive Regulatory Environment A supportive regulatory environment in South Korea plays a crucial role in fostering the growth of the vascular embolization market. The government actively encourages the development and approval of innovative medical devices through streamlined regulatory processes. This proactive approach facilitates quicker access to new embolization technologies, allowing healthcare providers to offer the latest treatment options to patients. In 2025, it is anticipated that regulatory approvals for new devices will increase by approximately 15%, reflecting the government's commitment to enhancing healthcare delivery. Such an environment not only boosts investor confidence but also encourages research and development in the vascular embolization market, ultimately leading to improved patient care and outcomes. ### Technological Innovations in Medical Devices Technological innovations in medical devices are transforming the landscape of the vascular embolization market. The introduction of advanced materials and imaging technologies enhances the precision and effectiveness of embolization procedures. For instance, the development of bioresorbable materials and improved catheter designs allows for more targeted and efficient embolization. In South Korea, the market for medical devices is projected to grow at a CAGR of 6% through 2025, indicating a robust environment for innovation. These advancements not only improve patient outcomes but also expand the range of treatable conditions, thereby driving the demand for vascular embolization procedures. As healthcare providers adopt these cutting-edge technologies, the vascular embolization market is poised for substantial growth. ### Rising Awareness of Minimally Invasive Procedures There is a growing awareness among patients and healthcare providers regarding the benefits of minimally invasive procedures, which serves as a catalyst for the vascular embolization market. As patients become more informed about their treatment options, they increasingly prefer procedures that offer reduced recovery times and lower risks of complications. This trend is particularly evident in South Korea, where educational campaigns and patient advocacy groups promote the advantages of embolization techniques. The vascular embolization market is likely to experience growth as more patients opt for these less invasive alternatives, leading to an increase in procedure volumes. Furthermore, healthcare professionals are also recognizing the efficacy of these techniques, which may result in a broader acceptance and implementation of embolization procedures in clinical practice. ## Future Outlook The [Vascular Embolization Market](https://www.marketresearchfuture.com/reports/vascular-embolization-market-11872) in South Korea is projected to grow at a 9.89% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare expenditure. **New opportunities:** - Development of biodegradable embolic agents for enhanced patient safety. - Expansion of telemedicine platforms for remote embolization consultations. - Investment in AI-driven imaging technologies for improved procedural accuracy. By 2035, the vascular embolization market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Technique: Coiling Devices (Largest) vs. Non-coiling Devices (Fastest-Growing) The South Korea vascular embolization market has seen a significant distribution of market share between coiling and non-coiling devices. Coiling devices currently command a substantial portion of the market due to their established efficacy and widespread acceptance among healthcare professionals. Non-coiling devices, while currently smaller in market share, are rapidly gaining traction as they offer innovative approaches to vascular embolization. Growth trends indicate a promising upward trajectory for both device types. Coiling devices are favored for their proven reliability in treating vascular conditions, while non-coiling devices are emerging due to advancements in technology and growing clinical evidence supporting their use. Factors driving this growth include increased awareness of vascular conditions, the aging population, and technological advancements enhancing the performance and safety of non-coiling options. Technique: Coiling Devices (Dominant) vs. Non-coiling Devices (Emerging) Coiling devices are the dominant force in the South Korea vascular embolization market. They are known for their reliability and effectiveness in achieving permanent occlusion of vascular sites. The extensive experience of clinicians with these devices contributes to their continued preference. Conversely, non-coiling devices represent the emerging trend within this segment. They incorporate advanced technologies, such as liquid embolics and occlusion balloons, which are increasingly recognized for their efficacy. As these options become more mainstream, non-coiling devices are expected to see rapid growth, fueled by innovations that enhance their usability and outcomes for patients. ### By Application: Oncology (Largest) vs. Neurology (Fastest-Growing) In the South Korea vascular embolization market, the application segment exhibits substantial diversity, with Oncology leading the market share. Peripheral Vascular Disease and Urology follow, demonstrating significant levels of demand. On the other hand, the Neurology segment is witnessing an impressive growth trajectory, reflecting an increasing awareness and advancement in treatment methodologies. Growth trends in this segment are predominantly driven by technological innovations and a rising prevalence of related health conditions. Emphasis on minimally invasive procedures and improved patient outcomes is also contributing to the rapid expansion of specific segments like Neurology. As healthcare providers continue to adopt modern embolization techniques, increased patient access to these services is anticipated, thereby enhancing the overall market dynamics. Oncology (Dominant) vs. Neurology (Emerging) Oncology is a dominant application within the South Korea vascular embolization market, recognized for its extensive use in tumor treatment, guiding practitioners in delivering effective interventions. This segment benefits from established clinical protocols and a significant commitment to research and development, ensuring it remains at the forefront of medical technology. Conversely, the Neurology segment, while emerging, is rapidly gaining traction due to advancements in neurovascular interventions and an increasing incidence of neurological disorders. The convergence of innovative techniques and a greater understanding of disease management positions Neurology as a vital contributor to the market's evolution, reflecting a promising area of growth for the near future. ## Competitive Benchmarking The vascular embolization market in South Korea is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Medtronic (US), Boston Scientific (US), and Terumo Corporation (JP) are actively pursuing strategies that enhance their market presence and operational efficiency. Medtronic (US) focuses on advancing its product portfolio through technological innovation, while Boston Scientific (US) emphasizes strategic acquisitions to bolster its capabilities in minimally invasive procedures. Terumo Corporation (JP) appears to be concentrating on expanding its manufacturing footprint in South Korea, which may enhance its supply chain resilience and responsiveness to local market demands.The business tactics employed by these companies reflect a moderately fragmented market structure, where localized manufacturing and supply chain optimization are pivotal. The collective influence of these key players suggests a competitive environment that is not only driven by product offerings but also by the ability to adapt to regional needs and regulatory landscapes. This adaptability is crucial as companies navigate the complexities of the South Korean healthcare system, which is known for its stringent regulations and high standards. In August Medtronic (US) announced the launch of a new embolization device designed specifically for the treatment of vascular malformations. This strategic move is significant as it not only expands Medtronic's product line but also positions the company to capture a larger share of the growing demand for innovative embolization solutions in South Korea. The introduction of this device is likely to enhance patient outcomes and solidify Medtronic's reputation as a leader in the vascular embolization space. In September Boston Scientific (US) completed the acquisition of a local medical device company specializing in embolization technologies. This acquisition is indicative of Boston Scientific's commitment to strengthening its market position through strategic mergers. By integrating local expertise and technologies, Boston Scientific may enhance its competitive edge and accelerate the development of new products tailored to the South Korean market. In October Terumo Corporation (JP) announced a partnership with a South Korean healthcare provider to co-develop advanced embolization techniques. This collaboration is noteworthy as it reflects Terumo's strategy to leverage local knowledge and resources, potentially leading to innovative solutions that address specific healthcare challenges in the region. Such partnerships may also facilitate quicker regulatory approvals and market entry for new products. As of November the competitive trends in the vascular embolization market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into product development and patient care. Strategic alliances are becoming more prevalent, allowing companies to pool resources and expertise to drive innovation. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to innovate and respond to evolving market demands. ## Recent News & Developments The South Korea Vascular Embolization Market has witnessed significant recent developments, particularly in the domains of technology and strategic movements. Companies such as AngioDynamics and Johnson and Johnson are focusing on advanced embolization techniques, enhancing the effectiveness of treatment options. In March 2023, Meritor, now acquired by BorgWarner, announced entering into collaborative agreements with Boston Scientific to expand accessibility of vascular embolization devices across various healthcare settings in South Korea.  The market has observed growth in valuation, primarily driven by the increasing prevalence of vascular diseases and the rising demand for minimally invasive procedures. Major players, including Abbott Laboratories and Terumo, have experienced a surge in product demand due to technological advancements and improved healthcare infrastructure. In the past two to three years, significant innovations, such as Hologic's enhanced imaging systems and Guerbet's new contrast agents, have further galvanized market interests. The South Korean government's continued investment in healthcare research and development is expected to bolster the Vascular Embolization sector's growth trajectory, signifying a robust future for both domestic and global players in this market. ## Report Scope | MARKET SIZE 2024 | 52.2(USD Million) | | --- | --- | | MARKET SIZE 2025 | 57.37(USD Million) | | MARKET SIZE 2035 | 147.25(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.89% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Terumo Corporation (JP), Johnson & Johnson (US), Stryker Corporation (US), B. Braun Melsungen AG (DE), Cook Medical (US), Abbott Laboratories (US), AngioDynamics (US) | | Segments Covered | Technique, Application | | Key Market Opportunities | Advancements in minimally invasive techniques enhance growth potential in the vascular embolization market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the vascular embolization market in South Korea. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What was the market valuation of the vascular embolization market in 2024?** A: The market valuation was $52.2 Million in 2024. **Q: What is the projected market valuation for 2035?** A: The projected market valuation for 2035 is $147.25 Million. **Q: What is the expected CAGR for the vascular embolization market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during the forecast period 2025 - 2035 is 9.89%. **Q: Which companies are considered key players in the vascular embolization market?** A: Key players include Medtronic, Boston Scientific, Terumo Corporation, Johnson & Johnson, Stryker Corporation, B. Braun Melsungen AG, Cook Medical, Abbott Laboratories, and AngioDynamics. **Q: What are the two main segments of the vascular embolization market?** A: The two main segments are Technique and Application. **Q: What was the valuation of coiling devices in the vascular embolization market?** A: The valuation of coiling devices was $20.88 Million in 2024 and is projected to reach $56.25 Million by 2035. **Q: What is the projected valuation for non-coiling devices by 2035?** A: The projected valuation for non-coiling devices is $91.0 Million by 2035. **Q: Which application segment had the highest valuation in 2024?** A: The Oncology application segment had the highest valuation at $15.0 Million in 2024. **Q: What is the projected valuation for the Peripheral Vascular Disease application by 2035?** A: The projected valuation for the Peripheral Vascular Disease application is $30.0 Million by 2035. **Q: How does the market for vascular embolization appear to be evolving in South Korea?** A: The market appears to be evolving positively, with a projected growth trajectory leading to a valuation of $147.25 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-vascular-embolization-market-52052*